-
Loading metrics
Open Access
Peer-reviewed
Research Article
Caerin 1.1 and 1.9 inhibit glioblastoma growth associated with modulation of the ARHGAP26-β-catenin axis and enhancing intratumoral CD8+ T cell infiltration
-
Furong Zhong ,
Contributed equally to this work with: Furong Zhong, Jinyi Wu
Roles Conceptualization, Data curation, Formal analysis, Validation, Writing – original draft
Affiliation The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China
⨯ -
Jinyi Wu ,
Contributed equally to this work with: Furong Zhong, Jinyi Wu
Roles Data curation, Formal analysis, Methodology, Writing – original draft
Affiliation The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China
⨯ -
Hongyin Wu,
Roles Formal analysis, Investigation, Software
Affiliation The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China
⨯ -
Yichen Wang,
Roles Investigation, Resources
Affiliation The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China
⨯ -
Fengyun Xiao,
Roles Methodology, Software
Affiliation The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China
⨯ -
Bin Xu,
Roles Investigation
Affiliation The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China
⨯ -
Junjie Li,
Roles Resources, Software
Affiliation Zhongao Biomedical Technology (Guangdong) Co., Ltd., Zhongshan, China
⨯ -
Yuandong Luo,
Roles Resources, Software
Affiliation Zhongao Biomedical Technology (Guangdong) Co., Ltd., Zhongshan, China
⨯ -
Quanlan Fu,
Roles Data curation, Methodology
Affiliation Zhongao Biomedical Technology (Guangdong) Co., Ltd., Zhongshan, China
⨯ -
Xiaosong Liu,
Roles Conceptualization, Methodology, Project administration, Supervision, Visualization
Affiliations The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China, Zhongao Biomedical Technology (Guangdong) Co., Ltd., Zhongshan, China, Cancer Research Institute, Foshan First People’s Hospital, Foshan, China
⨯ -
Tianfang Wang ,
Roles Conceptualization, Project administration, Writing – review & editing
* E-mail: twang@usc.edu.au (TW); ngy2003@gmail.com (GN); zhangw69@163.com (WZ)
Affiliations The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China, Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore, QLD, Australia, School of Science, Technology and Engineering, University of the Sunshine Coast, Maroochydore, QLD, Australia
⨯ -
Guoying Ni ,
Roles Formal analysis, Project administration, Resources, Writing – review & editing
* E-mail: twang@usc.edu.au (TW); ngy2003@gmail.com (GN); zhangw69@163.com (WZ)
Affiliations The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China, Zhongao Biomedical Technology (Guangdong) Co., Ltd., Zhongshan, China, Cancer Research Institute, Foshan First People’s Hospital, Foshan, China
⨯ -
Wei Zhang
Roles Funding acquisition, Supervision, Writing – review & editing
* E-mail: twang@usc.edu.au (TW); ngy2003@gmail.com (GN); zhangw69@163.com (WZ)
Affiliations The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China, Quality Assurance and Evaluation Center, Guangdong Pharmaceutical University, Guangzhou, China
⨯
Caerin 1.1 and 1.9 inhibit glioblastoma growth associated with modulation of the ARHGAP26-β-catenin axis and enhancing intratumoral CD8+ T cell infiltration
- Furong Zhong,
- Jinyi Wu,
- Hongyin Wu,
- Yichen Wang,
- Fengyun Xiao,
- Bin Xu,
- Junjie Li,
- Yuandong Luo,
- Quanlan Fu,
- Xiaosong Liu
- Published: July 9, 2026
- https://doi.org/10.1371/journal.pone.0353182